Antimicrobial Resistance Profile of Different Clinical Isolates against Rocephin
Tobruk University Journal of Medical Sciences · 2021
DOI: 10.64516/artgap34 ↗Abstract
Antibiotic-resistant microorganisms lead to more illness and deaths because they make treatments less effective. Therefore, information on antibiotic resistance helps guide the best possible treatment for different patients. Some bacteria, especially Gram-negative types, produce enzymes called beta-lactamases. These enzymes can break down the beta-lactam ring in antibiotics like ceftriaxone (Rocephin), making the drug ineffective. This study aimed to examine antibiotic resistance to Rocephin at Al Saleem Laboratory. A total of 206 patient samples were collected between September and November 2020. The clinical samples included wound swabs, urine, sputum, semen, blood, fluids, and samples from medical devices. These were taken from outpatients, and bacteria were identified using standard microbiology procedures. Antibiotic resistance was tested using the Kirby–Bauer disc diffusion method with Rocephin discs. In total, 604 bacterial isolates were identified—280 (46.3%) from female patients and 324 (53.6%) from male patients. The most common bacteria found were Escherichia coli (39.7%) and Klebsiella species (15.9%). Out of all isolates, 295 (48.8%) were resistant to ceftriaxone, 276 (45.7%) were still susceptible, and 33 (5.5%) had intermediate sensitivity. Resistance to ceftriaxone is increasing. Many of these resistant bacteria also showed resistance to multiple other antibiotics, which may make treatments less effective. Therefore, it's essential to choose the right antibiotic based on susceptibility testing results.
EUVIMED